Related Experiment Video
Updated: Jun 27, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Prenatal Screening for CMV Primary Infection: A Cost-Utility Model
Gebrael El Hachem1, Christian Renaud, Catherine McCarey
1School of Public Health, Université de Montréal (G.E.H., T.G.P., I.B.); Women and Children's Infectious Diseases Center, CHU Sainte-Justine Research Center (G.E.H., C.R., C.M., S.G., F.K., I.B.); Research Center of the IUSMM, CIUSSS de l'Est de l'Île de Montréal (T.G.P.); and Departments of Obstetrics and Gynecology (C.M.) and Pediatrics (C.R., S.G., F.K.), Université de Montréal, Montreal, Quebec, Canada; and Faculty of Medicine, Université Catholique de Louvain, Brussels, Belgium (M.S.).
Congenital cytomegalovirus (cCMV) affects approximately 1 in 200 Canadian newborns. This infection can lead to serious neurodevelopmental disabilities in children.
Area of Science:
- Neonatal Health
- Infectious Diseases
- Pediatric Neurology
Background:
- Congenital cytomegalovirus (cCMV) is a significant concern in neonatal populations.
- The prevalence of cCMV in Canada is approximately 1 in 200 live births.
- CMV infection in neonates can result in severe neurodevelopmental impairments.
More Related Videos
08:08qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue
Published on: July 9, 2014
10:24Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Cytomegalovirus Disease